EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

A Review of Natural and Synthetic Chalcones as Anticancer Agents Targeting Topoisomerase Enzymes

François-Xavier Toublet iD, Aurélie Laurent, Christelle Pouget

Molecules · 2025

DOI: 10.3390/molecules30122498 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Molecules, 2025. Verfasst von François-Xavier Toublet und 2 weiteren Autor:innen. Beteiligte Einrichtung: Univ. Limoges, LABCiS, UR 22722, Faculty of Pharmacy, F-87000 Limoges, France. Hauptthemen laut MEDLINE: Chalcones, Antineoplastic Agents, Topoisomerase Inhibitors. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 80 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cancer remains one of the leading causes of morbidity and mortality worldwide, driving the search for innovative and selective therapeutic agents. Topoisomerases I and II are essential enzymes involved in key cellular processes such as DNA replication and transcription. They have emerged as valuable anticancer targets; thus, many inhibitors of topoisomerases have been designed and some of them are considered to be major anticancer agents such as anthracyclines, etoposide or irinotecan. A great deal of attention is currently being paid to chalcones, a class of naturally occurring compounds, since they exhibit a wide range of biological activities, including anticancer properties. These compounds are characterized by an open-chain structure and an α,β-unsaturated carbonyl moiety that enables interaction with cellular targets. Recent studies aiming to design anti-topoisomerase agents have identified both natural and synthetic chalcones, including chalcone-based hybrids. This review highlights the structural diversity of chalcones as topoisomerase inhibitors and particular attention is given to structure–activity relationship studies and molecular hybridization strategies aimed at optimizing the pharmacological profile of chalcones. These findings underline the potential of chalcones as promising scaffolds in the design of next-generation anticancer agents.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ChalconesAntineoplastic AgentsTopoisomerase InhibitorsHumansStructure-Activity RelationshipNeoplasmsDNA Topoisomerases, Type IIDNA Topoisomerases, Type IAnimalsMolecular StructureDNA TopoisomerasesTopoisomerase I Inhibitors

Stichwörter der Autor:innen

cancerchalcone hybridsnatural chalconessynthetic chalconestopoisomerases

Substanzen

ChalconesAntineoplastic AgentsTopoisomerase InhibitorsDNA Topoisomerases, Type IIDNA Topoisomerases, Type IDNA TopoisomerasesTopoisomerase I Inhibitors

Autor:innen und Institutionen

  • Univ. Limoges, LABCiS, UR 22722, Faculty of Pharmacy, F-87000 Limoges, France.

ORCID-Profile: François-Xavier Toublet

Zitieren

APA

Toublet, F. X., Laurent, A., & Pouget, C. (2025). A Review of Natural and Synthetic Chalcones as Anticancer Agents Targeting Topoisomerase Enzymes. Molecules. https://doi.org/10.3390/molecules30122498

Vancouver

Toublet FX, Laurent A, Pouget C. A Review of Natural and Synthetic Chalcones as Anticancer Agents Targeting Topoisomerase Enzymes. Molecules. 2025. doi:10.3390/molecules30122498

BibTeX
@article{Toublet2025,
  author = {Toublet, François-Xavier and Laurent, Aurélie and Pouget, Christelle},
  title = {A Review of Natural and Synthetic Chalcones as Anticancer Agents Targeting Topoisomerase Enzymes},
  journal = {Molecules},
  year = {2025},
  doi = {10.3390/molecules30122498}
}
Kostenlos starten →